Sign in

CIK 0001737287

  • Non-accelerated filer
  • Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
823562771
Phone
+1 650-457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,698
in 1 filing

Net −$48,698. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Parker Geoffrey M. −$49K CHIEF FINANCIAL OFFICER sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-18 Barrett Elizabeth A. Director Grant or award · Restricted Stock Unit +95,400 95,400
2025-06-18 Barrett Elizabeth A. Director Grant or award · Restricted Stock Unit +95,400 95,400
2024-06-05 Barrett Elizabeth A. Director Grant or award · Stock Option (Right to buy) +191,082 191,082
2023-06-13 Barrett Elizabeth A. Director Grant or award · Stock Option (Right to Buy) +116,120 116,120
2022-06-15 Barrett Elizabeth A. Director Grant or award · Stock Option (Right to Buy) +71,070 71,070
2021-07-30 Barrett Elizabeth A. Director Grant or award · Stock Option (Right to Buy) +63,385 63,385

Page 1 of 1 · 6 trades